# Elysium Pharmaceuticals Limited, Dabhasa, India – FDA Inspections

Source: https://www.keypedia.com/companies/elysium-pharmaceuticals-limited/6249fc41-1206-431f-87ee-b7b13c89e8f4

> Inspection records and compliance data for Elysium Pharmaceuticals Limited in Dabhasa. 4 FDA inspections on record, 1 Form 483, last inspected January 16, 2023.

---

## Details

- Name: Elysium Pharmaceuticals Limited
- FEI Number: 3005183272
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Plot 1175, Taluka
- City: Dabhasa
- Country Name: India
- Address: Plot 1175, Taluka, Dabhasa, India
- Country: India

## Related Documents

- [483 - Elysium Pharmaceuticals Limited - 2023-01-16](https://www.keypedia.com/records/483/elysium-pharmaceuticals-limited/d3c9a254-7ccd-4b13-b5e1-b296f0d7a521) — source: FDA, date: January 16, 2023
- [FDA Inspection 1195116 - Elysium Pharmaceuticals Limited - 2023-01-16](https://www.keypedia.com/records/fda_inspections/elysium-pharmaceuticals-limited/9ed57172-98d1-404f-9159-be89805611dd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 16, 2023
- Canada Inspection - Elysium Pharmaceuticals Limited - Inspection #82744 - 2023-01-09 — source: Canada, date: January 9, 2023
- Canada Inspection - Elysium Pharmaceuticals Limited - Inspection #82738 - 2023-01-09 — source: Canada, date: January 9, 2023
- FDA Inspection 1061759 - Elysium Pharmaceuticals Limited - 2018-07-13 — source: FDA, date: July 13, 2018
- [Canada Inspection - Elysium Pharmaceuticals Limited - Inspection #71505 - 2018-07-09](https://www.keypedia.com/records/canada_inspection/elysium-pharmaceuticals-limited/eee6994a-89f8-4bf0-a696-a97c0d9b1962) — source: Canada, date: July 9, 2018
- FDA Inspection 1030263 - Elysium Pharmaceuticals Limited - 2017-09-08 — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2017
- Canada Inspection - Elysium Pharmaceuticals Limited - Inspection #71137 - 2017-09-04 — source: Canada, date: September 4, 2017
- FDA Inspection 911280 - Elysium Pharmaceuticals Limited - 2014-12-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 26, 2014
- Canada Inspection - Elysium Pharmaceuticals Limited - Inspection #13157 - 2014-12-22 — source: Canada, date: December 22, 2014

## Related Companies

- [Stallion Laboratories Private Limited](https://www.keypedia.com/companies/stallion-laboratories-private-limited/20b4f144-435c-4f1c-8724-5ff1dca85264)
- [IntelliPharmaCeutics Corp.](https://www.keypedia.com/companies/intellipharmaceutics-corp/78f18be2-f4f4-44f4-88d7-30d9f8f36ac5)
- [Hospira, Inc., A Pfizer Company](https://www.keypedia.com/companies/hospira-inc-a-pfizer-company/46d63c80-caf7-40db-8325-13fcade5e82c)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Italfarmaco S.A.](https://www.keypedia.com/companies/italfarmaco-sa/1c87038a-ed84-4bfa-bb11-1fd51ce8eacd)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)
- [Italfarmaco S.p.A.](https://www.keypedia.com/companies/italfarmaco-spa/43c36cab-e301-4482-b9f7-b042cce56271)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/a73360d0-4ea2-40a4-aa12-221cece9173f)
- [Century Pharmaceuticals, Inc.](https://www.keypedia.com/companies/century-pharmaceuticals-inc/d3898136-aa03-4edc-b005-44709b7f4c67)
- [Catalent Belgium SA](https://www.keypedia.com/companies/catalent-belgium-sa/f48653bf-84a2-4aeb-bdc3-ca2d0cc4fdf2)

## Related Officers

- [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce)
- [Consumer Safety Officer (Drug Specialist)](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
